Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Dacarbazine
  • Melanoma

abstract

  • The combination of temozolomide plus thalidomide seems to be a promising and well-tolerated oral regimen for metastatic melanoma that merits further study.

publication date

  • September 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2003.02.061

PubMed ID

  • 12947072

Additional Document Info

start page

  • 3351

end page

  • 6

volume

  • 21

number

  • 17